Planning design of locally advanced pancreatic carcinoma using 4DCT and IMRT/IGRT technologies

Acta Oncologica

Volumn 50, Issue 1, 2011, Pages 72-80

  Sangalli, Giulia ^a,b   Passoni, Paolo ^a   Cattaneo, Giovanni M ^a   Broggi, Sara ^a   Bettinardi, Valentino ^a   Reni, Michele ^a   Slim, Najla ^a   Muzio, Nadia Di ^a   Calandrino, Riccardo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER RADIOTHERAPY; CANCER SIZE; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PANCREAS CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; TOMOTHERAPY; TREATMENT PLANNING;

ADULT; AGED; DUODENUM; FEMALE; FOUR-DIMENSIONAL COMPUTED TOMOGRAPHY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME;

EID: 78650547819     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.484425     Document Type: Article

References (26)

1. Crane CH, Varadhachary G, Pisters PW, Evans DB, Wolff RA. Future chemoradiation strategies in pancreatic cancer. Semin Oncol 2007;34:335-46. (Pubitemid 47176616)
2. Murphy JD, Adusumilli S, Griffith KA, Ray ME, Zalupski MM, Lawrence TS, et al. Full dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 2007:68:801-8. (Pubitemid 46818734)
3. Russo S, Butler J, Ove R, Blackstock AW. Locally advanced pancreatic cancer: A review. Semin Oncol 2007;34:327-34. (Pubitemid 47176622)
4. Huguet F, André T, Hammel P, Artru P, Balosso J, Selle F, et al. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR Phase II and III Studies. J Clin Oncol 2007;20:326-31. (Pubitemid 350003022)
5. Reni M, Cordio S, Milandri C, Passoni P, Bonetto E, Oliani C, et al. Gemcitabine versus cisplatin, epirubicin, fl uorouracil, and gemcitabine in advanced pancreatic cancer: A randomized controlled multicentre phase III trial. Lancet Oncol 2005;6:369-76. (Pubitemid 40753742)
6. Spalding AC, Jee KW, Vineberg JK, Jablonowski M, Fraass BA, Pan CC, et al. Potential for dose-escalation and reduction of risk in pancreatic cancer using IMRT optimization with lexicographic ordering and gEUD-based cost function. Med Phys 2007;34:521-9. (Pubitemid 46185131)
7. Keall PJ, Mageras GS, Balter JM, Emery RS, Forster KM, Jiang SB, et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys 2006;33:3874-900.
8. Mancosu P, Bettinardi V, Passoni P, Gusmini S, Cappio S, Gilardi MC, et al. Contrast enhanced 4D-CT imaging for target volume defi nition in pancreatic ductal adenocarcinoma. Radiother Oncol 2008;87:339-42.
9. Ben-Josef E, Shields AF, Vaishampayan U, Vaitkevicius V, El-Rayes BF, McDermott P, et al. Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. Int J Radiat Oncol Biol Phys 2004;59:454-9. (Pubitemid 38622600)
10. Brown MW, Ning H, Arora B, Albert PS, Poggi M, Caphausen K, et al. A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma. Int J Radiat Oncol Biol Phys 2006;65:274-83.
11. Milano MT, Chmura SJ, Garofalo MC, Rash C, Roeske JC, Connell PP, et al. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: Toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 2004;59: 445-53. (Pubitemid 38622599)
12. Cattaneo GM, Dell'Oca I, Broggi S, Fiorino C, Perna L, Pasetti M, et al. Treatment planning comparison between conformal radiotherapy and helical tomotherapy in case of locally advanced stage NSCLC. Radiother Oncol 2008;88:310-8.
13. Iori M, Cattaneo GM, Cagni E, Fiorino C, Borasi G, Calandrino R, et al. Dose-volume and biological-model based comparison between helical tomotherapy and (inverseplanned) IMAT for prostate tumours. Radiother Oncol 2008;88:34-45.
14. Widesott L, Pierelli A, Fiorino C, Dell'Oca I, Broggi S, Cattaneo GM, et al. Intensity modulated proton therapy vs helicoidal tomotherapy in nasopharynx cancer. Planning comparison and NTCP evaluation. Int J Radiat Oncol Biol Phys 2008;72:589-96.
15. Fiorino C, Di Muzio N, Broggi S, Cozzarini C, Maggiulli E, Alongi F, et al. Evidence of limited motion of the prostate by carefully empting the rectum as assessed by daily MVCT image guidance with Helical Tomotherapy. Int J Radiat Oncol Biol Phys 2008;71:611-7.
16. Li AX, Qi XS, Pitterle M, Kalakota K, Mueller K, Erickson Ba, et al. Interfractional variations in patients setup and anatomic change assessed by daily computed tomography. Int J Radiat Oncol Biol Phys 2007;68:581-91. (Pubitemid 46694164)
17. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991;21:123-35.
18. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21: 109-22.
19. Sanchez-Nieto B, Nahum AE. BIOPLAN: Software for the biological evaluation of radiotherapy treatment plans. Med Dosim 2000;25:71-6. (Pubitemid 30336646)
20. Kim YS, Park SH, Ahn SD, Lee JE, Choi EK, Lee SW, et al. Differences in abdominal organ movement between supine and prone positions measured using four-dimensional computed tomography. Radiother Oncol 2007;85:424-8.
21. Van der Geld YG, van Triest B, Verbakel WF, Verbakel WFAR, van Sornsen de Koste JR, Senan S, et al. Evaluation of four-dimensional computed tomography-based-intensitymodulated and respiratory-gated radiotherapy techniques for pancreatic carcinoma. Int J Radiat Oncol Biol Phys 2008;72:1215-20.
22. Xi M, Liu MZ, Deng XW, Zhang L, Huang XY, Liu H, et al. Defi ning internal target volume (ITV) for hepatocellular carcinoma using four-dimensional CT. Radiother Oncol 2007;84:272-8. (Pubitemid 47362405)
23. Ceha HM, van Tienhoven G, Gouma DJ, Veenhof CHN, Schneider CJ, Rauws EAJ, et al. Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma. Cancer 2000; 89:222-9.
24. Talamonti MS, Small W, Mulcahy MF, Wayne JD, Attaluri VA, Colletti LM, et al. A multi-institutional Phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma. Ann Surg Oncol 2006;13:150-8. (Pubitemid 43157408)
25. Abratt RP, Bogart JA, Hunter A. Hypofractionated irradiation for non-small cell lung cancer. Lung Cancer 2002;36: 225-33. (Pubitemid 34497119)
26. Fowler JF, Tomé WA, Fenwick JD, Mehtha PM. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 2004;60:1241-56.